Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Annals of Hepatology|January 3, 2019
Improvement in Waldenström's Macroglobulinemia after Successful Treatment of HCV with Direct-acting AntiviralsMattia Crespi, Maria Giulia Demarzo, Matteo Brunacci, et al.
Cardiovascular Research|October 11, 2005
Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidasePaolo Spallarossa, Paola Altieri, Silvano Garibaldi, et al.
Cancer Genetics and Cytogenetics|May 28, 2008
A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemiaGabriella Cirmena, Stefania Aliano, Giuseppina Fugazza, et al.
Lancet (London, England)|July 26, 2005
Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancerAngelo M Carella, Germana Beltrami, Maria T Corsetti, et al.
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|May 31, 2016
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trialNicoletta Castagnino, Massimo Maffei, Lorenzo Tortolina, et al.
Scientific Reports|January 19, 2016
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancerDavid N Brown, Irene Caffa, Gabriella Cirmena, et al.
European Journal of Immunology|February 16, 2006
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cellsAlessio Nencioni, Anna Garuti, Karin Schwarzenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cellsAlessio Nencioni, Lucia Wille, Giovanna Dal Bello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cellsAlberto Ballestrero, Alessio Nencioni, Davide Boy, et al.
Pageof 13